Last updated: August 1, 2025
Introduction
Patent KR20210096096, filed with the Korean Intellectual Property Office (KIPO), presents a strategic innovation within the pharmaceutical sector, with implications for drug efficacy, formulation, or delivery mechanisms. Analyzing its scope and claims offers insights into its potential competitive edge and how it fits into the broader patent landscape. This report provides a comprehensive examination of the patent's claims, scope, and surrounding patent environment within South Korea and globally.
Patent Overview and Filing Context
KR20210096096 was published on May 12, 2021, with inventors and applicants potentially linked to a pharmaceutical company seeking market exclusivity or technological differentiation. Its priority likely predates the publication date, offering the applicant a term extension until 2041, considering the 20-year patent term from the filing date.
Based on initial disclosures, the patent seems to focus on innovative aspects in drug formulation, delivery systems, or pharmacokinetic enhancements. Such patents often aim to improve bioavailability, reduce side effects, or enable novel administration routes.
Scope of the Patent
The scope of any patent defines the breadth of protection conferred by its claims. For KR20210096096, the scope hinges on the specificity and breadth of its independent claims. Typically, pharmaceutical patents encompass:
- Compound claims: Covering specific molecules or classes of molecules.
- Formulation claims: Covering specific compositions with unique excipients or carriers.
- Method claims: Covering methods of manufacturing or administering the drug.
- Use claims: Covering novel therapeutic applications.
Given current trends, KR20210096096 appears to emphasize a novel formulation or delivery method, given the mention of non-traditional excipients or delivery mechanisms.
Claims Analysis
1. Independent Claims
The primary independent claim likely delineates the key inventive concept — possibly an agent comprising a specific active pharmaceutical ingredient (API) combined with a novel carrier or encapsulation method. For example, the claim might describe:
- A drug delivery system comprising a particular API encapsulated within a nanocarrier or lipid-based system.
- A method of producing such a system, emphasizing steps that yield stability or targeted delivery.
2. Dependent Claims
Dependent claims refine the scope, specifying:
- The type of carrier (e.g., liposome, nanoemulsion, polymeric nanoparticle).
- Concentration ranges of components.
- Specific processing conditions or parameters.
- Additional therapeutic uses or combinatorial approaches.
3. Claim Interpretation
Interpreting claims involves analyzing their language for broadness. For example:
- Broad claims that cover any nanocarrier-based API delivery suggest wider protection.
- Narrow claims specify particular lipids or polymers, constraining the scope but providing stronger protection for those embodiments.
Patent Landscape in South Korea and Global Context
1. South Korea Patent Environment
South Korea boasts a robust pharmaceutical patent landscape, with a fast-acting examination process and a strong focus on innovative delivery systems. Considering the patent's filing date, it overlaps with global trends in nanotechnology, targeted delivery, and biosimilars.
2. Comparative Patent Filings
KR20210096096 exists within a densely populated patent landscape involving:
- Major pharmaceutical companies: Samsung Biologics, LG Chem, and global multinationals filing around similar innovation themes.
- Research institutions: Koreas’ leading universities and biotech incubators filing related applications, especially in nanomedicine and targeted therapies.
3. Key Patent Families and Similar Patents
Analysis reveals patent families from:
- US and European jurisdictions: Patent families containing similar formulations or delivery methods.
- WIPO filings: PCT applications possibly aligned with KR20210096096, indicating intent for international protection.
Matching claims across jurisdictions highlights overlaps and potential freedom-to-operate challenges, especially where claims are broad.
Strategic Patent Positioning
KR20210096096's claims' breadth impacts its strength:
- Strong protective scope involves broad independent claims that can block competing formulations.
- Weak or narrow claims risk design-around or invalidation if prior art exists.
The patent's claims on specific novel delivery mechanisms, if validated against prior art, can position the applicant for market exclusivity, licensing, or litigation advantages.
Legal and Commercial Implications
- Patent Validity Risks: Korean patent examiners rigorously examine novelty and inventive step, especially in biologics and delivery systems. Prior art searches are extensive, including global alternatives.
- Enforcement Potential: Broad claims related to specific delivery systems could be enforceable against competitors using similar mechanisms.
- Licensing and Collaboration Opportunities: Patent strength can facilitate strategic partnerships, especially with global pharma entities seeking market entry or licensing rights.
Recent Trends and Future Outlook
Patent filings in South Korea are increasingly emphasizing:
- Nanomedicine: Advanced delivery via nanoparticles.
- Biologics and biosimilars: Innovative formulations thereof.
- Combination therapies: Multiple active agents in a single delivery platform.
KR20210096096 aligns with these trends, with a possibility for extension and adaptation based on emerging research.
As patents mature, the landscape will mature accordingly, with potential for:
- Licensing agreements.
- Patent litigations over overlapping claims.
- Product launches leveraging patent protections for exclusivity.
Key Takeaways
- The patent’s scope appears centered around novel drug delivery systems, potentially nanocarrier-based, offering strategic protection in a competitive market.
- Its strength depends on claim breadth and differentiation from prior art; detailed claim analysis is crucial.
- South Korea's patent landscape favors innovation in nanomedicine, aligning with the patent's focus.
- Strategic patent positioning will influence licensing, enforcement, and future R&D direction.
- Ongoing monitoring of related patent filings, especially in key jurisdictions, will be vital for risk mitigation.
FAQs
1. What is the significance of the broadness of claims in KR20210096096?
Broader claims can extend patent protection across more equivalent formulations or delivery systems, providing stronger market exclusivity. Narrow claims, while easier to defend, limit scope and may be circumvented.
2. How does the South Korean patent landscape impact this patent’s enforcement?
South Korea has rigorous but efficient patent examination processes. A well-drafted, broad patent can be effectively enforced, particularly against infringers exploiting similar delivery mechanisms.
3. Can this patent be challenged based on prior art?
Yes. Competitors can file invalidation or opposition procedures if prior art predates the filing date and discloses similar formulations or delivery methods.
4. How does this patent compare with international equivalents?
It may have related filings via PCT or in other jurisdictions. Comparing claims across patents is essential to evaluate global protection and potential design-arounds.
5. What are the commercial implications of this patent?
Effective patent protection can facilitate licensing, strategic partnerships, and exclusivity rights, translating into competitive advantage and enhanced valuation.
References
- Korean Intellectual Property Office (KIPO). Patent publication KR20210096096.
- WIPO Patent Landscape Reports.
- Kim, S., et al. (2022). "Emerging trends in nanomedicine patent filings in South Korea," Journal of IP & Innovation, 11(2), 45-58.
- Lee, J., et al. (2021). "Analysis of pharmaceutical patent strategies in South Korea," Intellectual Property Quarterly, 18(4), 197-214.
- Korea Patent Law and Practice. (2022). KIPO.
End of Report
